1. How many patients has your trust/health board treated in the past 6 months (for any disease) with the following drugs:
a. Aubagio (teriflunomide)
b. Avonex (interferon beta-1a)
c. Betaferon (interferon beta-1b)
d. Brabio (glatiramer acetate)
e. Copaxone (glatiramer acetate)
f. Extavia (beta interferon-1b)
g. Gilenya (fingolimod)
h. Lemtrada (alemtuzumab)
i. Kesimpta (ofatumumab)
j. Mavenclad (cladribine)
k. Mayzent (siponimod)
l. Ocrevus (ocrelizumab)
m. Plegridy (peginterferon beta-1a)
n. Ponvory (ponesimod)
o. Rebif (beta interferon-1a)
p. Tecfidera (dimethyl fumarate)
q. Tysabri (natalizumab)
r. Tysabri (natalizumab) pre-filled syringes ONLY
s. Vumerity (diroximel fumarate)
t. Zeposia (ozanimod)
2. It would also be very helpful if you could advise how many hospital patients seen in the past 6 months (as inpatients or outpatients) have a diagnosis for the following conditions:
a. Multiple sclerosis (any type)
b. Relapsing remitting multiple sclerosis (RRMS)
c. Primary progressive multiple sclerosis (PPMS)
d. Secondary progressive multiple sclerosis (SPMS)
